IP Library › Assignment 059267/0067
Patent Assignment
Reel/Frame 059267/0067

Security Interest

Recorded: 2022-03-15 Pages: 7
Assignors
REACTION BIOLOGY CORPORATION
Executed: 2022-03-15
JAKPHARM, LLC
Executed: 2022-03-15
Assignee
GOLUB CAPITAL LLC, AS COLLATERAL AGENT
100 SOUTH WACKER DRIVE, CHICAGO, ILLINOIS, 19355
Covered Properties (7)
Selective Kinase Inhibitors
Patent: 8,592,415 →
Application: 12/704,404 →
Publication: US 2011/0071149
Inhibition of Activated CDC42-Associated Kinase 1
Patent: 8,658,655 →
Application: 13/429,755 →
Publication: US 2012/0245173
Histone Deacetylase Inhibitors and Methods for Use Thereof
Application: 15/234,412 →
Publication: US 2017/0044185
Selective Kinase Inhibitors
Application: 15/360,198 →
Publication: US 2017/0143706
Quinoline and Isoquinoline Based HDAC Inhibitors and Methods of Use Thereof
Application: 16/290,136 →
Publication: US 2019/0270733
Histone Deacetylase Inhibitors and Methods of Use Thereof
Application: 16/290,174 →
Publication: US 2019/0270744
Histone Deacetylase Inhibitors and Methods of Use Thereof
Application: 17/487,279 →
Publication: US 2022/0017518
Related Assignments (14)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 2, 2010
From: KEY ORGANICS LTD
To: SYNERGA LIMITED
Reel/Frame 024180/0774 →
Assignment of Assignor's Interest Apr 2, 2010
From: FILIP, SORIN VASILE
To: KEY ORGANICS LTD
Reel/Frame 024180/0665 →
Assignment of Assignor's Interest Apr 2, 2010
From: MA, HAICHING
To: REACTION BIOLOGY CORP.
Reel/Frame 024180/0493 →
Assignment of Assignor's Interest Sep 5, 2013
From: STENT, MATTHEW ALEXANDER HENRY; DOLAN, JAMES ALEXANDER; DIETRICH, BARTOSZ
To: SYNERGA LIMITED
Reel/Frame 031147/0045 →
Nunc Pro Tunc Assignment Nov 24, 2015
From: SYNERGA LIMITED
To: KEY ORGANICS LTD.
Reel/Frame 037134/0157 →
Confirmatory License Sep 6, 2017
From: FOX CHASE CANCER CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 043761/0555 →
Assignment of Assignor's Interest Apr 16, 2018
From: MA, HAICHING; WANG, YUREN
To: REACTION BIOLOGY CORP.
Reel/Frame 045551/0425 →
Assignment of Assignor's Interest May 1, 2018
From: REACTION BIOLOGY CORPORATION
To: JAKPHARM, LLC
Reel/Frame 045682/0970 →
Assignment of Assignor's Interest May 1, 2018
From: MA, HAICHING
To: REACTION BIOLOGY CORPORATION
Reel/Frame 045682/0826 →
Assignment of Assignor's Interest May 22, 2018
From: ACLARIS THERAPEUTICS, INC.
To: JAKPHARM, LLC
Reel/Frame 045872/0804 →
Assignment of Assignor's Interest Jan 31, 2020
From: MA, HAICHING; FENG, YANGBO; WANG, YUREN
To: REACTION BIOLOGY CORP.
Reel/Frame 051684/0387 →
Assignment of Assignor's Interest Jan 31, 2020
From: MA, HAICHING; FENG, YANGBO
To: REACTION BIOLOGY CORP.
Reel/Frame 051684/0283 →
Assignment of Assignor's Interest Jun 8, 2020
From: THE FOX CHASE CANCER CENTER FOUNDATION
To: THE INSTITUTE FOR CANCER RESEARCH
Reel/Frame 053562/0938 →
Assignment of Assignor's Interest Aug 8, 2022
From: MA, HAICHING; FENG, YANGBO; WANG, YUREN
To: REACTION BIOLOGY CORP.
Reel/Frame 060740/0272 →